This announcement is a separate document:
麗珠醫藥：2022 年股票期權激勵計劃首次授予登記完成
LIVZON PHARMA: COMPLETION OF REGISTRATION OF THE FIRST GRANT OF THE 2022 SHARE OPTIONS INCENTIVE SCHEME
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.